HER Foundation

@HGmoms

HER Foundation is the voice of HG, a pregnancy condition that increases risk of maternal & fetal mortality and morbidity.

כאן מאז מרץ 2012

ציוצים

חסמת את @HGmoms

האם אתה בטוח שאתה רוצה להציג את הציוצים האלה? הצגת הציוצים לא תגרום לשחרור של @HGmoms

  1. ציוץ נעוץ
    13 בפבר׳

    Imagine consistent standards of care to reduce suffering and preventable complications of HG. Be part of HG Progress! Support another 20 years of helping mothers & babies thrive: .

    ביטול
  2. לפני 5 שעות
    ביטול
  3. לפני 6 שעות

    In 2007, 15% of women reported therapeutic terminations of wanted pregnancies due to HG primarily because of no hope for relief & more often reported uncaring providers. The rate is now 6% due in part to the education & support provided by HER. .

    ביטול
  4. לפני 6 שעות

    Thiamin (100 mg/day) must become standard of care for women with Hyperemesis Gravidarum! Daily thiamin prevents serious complications including Wernicke's encephalopathy. WE Fact Sheet: .

    ביטול
  5. לפני 9 שעות

    Support women at risk for PMADs! Earn 16 ceus over two days training with Elizabeth Lowder MSW, LCSW and Kim Martino-Sexton NFC will train participants on their “Heartland Protocol” for PMADs. May 5-6: .

    ביטול
  6. 27 באפר׳

    Do you have patients with refactory HG? Consider granisetron. Samples are available here: . (HER is not affiliated with Sancuso.)

    ביטול
  7. 27 באפר׳
    ביטול
  8. 27 באפר׳

    May 15th is HG Awareness Day! The international HG community is shining light on HG Truths all month! Don't miss any events, education, and advocacy: .

    ביטול
  9. 27 באפר׳

    Our own Danielle Plummer, PharmD and member of HER's Board can be heard talking about her HG experience on Dose of Support podcast. Don't miss it: .

    ביטול
  10. 26 באפר׳

    The HyperEmesis Level Prediction Score developed by the HER Foundation quantifies HG symptoms into a score that can be trended over time to monitor progress and response to treatment: .

    , ‏, ועוד 7 נוספים
    ביטול
  11. 26 באפר׳

    In March hosted a webinar: Impact of COVID-19 and Women’s Health Challenges & Lessons. HER joined AHN, , & other experts to discuss the impact of COVID-19 on women’s access to healthcare services: .

    ביטול
  12. 26 באפר׳

    Our March Volunteer in Action is ! She is HER's Medical Advisor, a member of the Board of Directors. Thank you for all you do, Aimee!

    ביטול
  13. 25 באפר׳

    We're advancing current guidelines by developing a comprehensive treatment algorithm to help clinicians in managing HG. It takes ACOG guidelines and recommended treatment options and puts them into a practical format. Download: .

    ביטול
  14. צייץ מחדש
    24 באפר׳
    ביטול
  15. צייץ מחדש
    25 באפר׳

    When you minimise confounding by indication + do a proper time of exposure analysis, ondansetron in pregnancy doesn’t increase risk of fetal death or malformation

    ביטול
  16. 25 באפר׳

    Join us Live at 5 PM/Pacific on Instagram, 4/25: . Kimber MacGibbon, RN, and Danielle Plummer, PharmD, will talk about advocating for better care.

    ביטול
  17. 25 באפר׳

    There are many strategies to optimize HG treatment. HER Foundation has developed evidence-based tools to support you in caring for your patients: .

    ביטול
  18. 25 באפר׳
    ביטול
  19. 24 באפר׳

    Have you read our study demonstrating the effectiveness of the HyperEmesis Level Prediction (HELP) Score in identifying pregnant women with severe symptoms of nausea and vomiting in pregnancy (NVP)? Study: .

    ביטול
  20. 23 באפר׳
    ביטול
  21. 23 באפר׳

    HG has an 80% recurrence rate, so it is best for HG patients to be prepared for a subsequent pregnancy: .

    ביטול

מסתבר כי הטעינה לוקחת זמן־מה.

ייתכן שיש עומס או תקלה זמנית בטוויטר. נסה שוב או בקר בדף המצב של טוויטר לקבלת מידע נוסף.

    ייתכן שגם ימצא חן בעיניך

    ·